Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cellex
Biotech
Blackstone, Cellex and Intellia form $250M CAR-T startup
The biotech begins life with $250 million from Blackstone, CAR-T platforms from Cellex and CRISPR/Cas9 genome editing technology from Intellia.
Nick Paul Taylor
Jun 22, 2021 8:30am
Fierce Medtech's 2020 Top 10: COVID testing's ups and downs
Dec 23, 2020 9:20am
Cellex, Gauss set sights on smartphone-powered coronavirus test
Sep 17, 2020 3:05pm
FDA authorizes its first antibody blood test for COVID-19
Apr 3, 2020 10:30am
